American CryoStem Corporation entered into a licensing agreement with Cell Source (CS). Under terms of the agreement, American CryoStem has licensed to CS the rights to utilize its Standard Operating Procedures (SOP's) to create and market its ATGRAFT(TM) tissue storage service in Japan.
American CryoStem Corporation
Equities
CRYO
US0253001046
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.47% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |